Kozawa, J., Kitamura, T., Nishizawa, H., Yasuda, T., Maeda, N., Otsuki, M., . . . Shimomura, I. (2012). Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance. Wiley-Blackwell.
Citação norma ChicagoKozawa, Junji, et al. Dipeptidyl Peptidase‐4 Inhibitors Are Effective in Japanese Type 2 Diabetic Patients With Sustained Endogenous Insulin‐secreting Capacity, a Higher Body Mass Index and Insulin Resistance. Wiley-Blackwell, 2012.
ציטוט MLAKozawa, Junji, et al. Dipeptidyl Peptidase‐4 Inhibitors Are Effective in Japanese Type 2 Diabetic Patients With Sustained Endogenous Insulin‐secreting Capacity, a Higher Body Mass Index and Insulin Resistance. Wiley-Blackwell, 2012.